CIK 0001723128 · Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- Phone
- (908) 947-3120
- Former names
- Atlas Holdings, Inc.
- 4 Shares withheld for taxes Executive Vice President gave up 21,925 shares (to pay taxes)
- S-3ASR Offering Registration Statement
- S-3ASR Offering Registration Statement
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Shares withheld for taxes Executive Vice President gave up 11,107 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 11,695 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 16,434 shares (to pay taxes)
- 10-K Report Annual Report
- SC 13G/A Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Open-market buy Director bought 50,000 shares at $4.21 ($210,500)
- 4 Open-market buy President & Co-CEO bought 150,000 shares at an average $4.17 ($625,500)
- 4 Open-market buy Co-CEO bought 150,000 shares at an average $4.17 ($625,500)
- 4 Open-market sale Executive Vice President sold 2,000 shares at $3.95 ($7,900)
- 4 Open-market sale Executive Vice President sold 1,500 shares at $4.10 ($6,150)
- 10-Q Report Quarterly Report
Page 19 of 35 · 695 filings